Skip to main content

Table 2 Patient Leukapheresis Settings

From: Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients

Leukapheresis data

n (%) or Median

Leukapheresis

132 (100)

Venous access 2-arm continuous flow

108 (82)

1-arm continuous flow

24 (18)

Apheresis machine Baxter CS3000

62 (47)

Haemonetics MC5-P

18 (14)

COBE Spectra

52 (39)

Mean total run time (min)

88 (range 43–155)

Total time* (door to door, min)

155 (73–260)

Median Volume processed (L)

4.6 (0.52–5.68)

Median whole blood flow rate (mL/min)

60 (range 35–85)

Median product volume (mL)

147 (range 59–450 )

  1. *Door to door time is defined as the duration of time from arrival to Apheresis Center to discharge